Advances in Nano-Therapeutics: Spotlight on Cerium Oxide

  • Magazine Article
  • TBMG-29744
Published July 01, 2018 by Tech Briefs Media Group in United States
  • English

For decades, the pharmaceutical industry has focused its drug-development strategies around the use of organic or biologically derived compounds. Among numerous successes are also a multitude of failed drug products due to a variety of factors including solubility, stability, biopersistence, and undesired secondary or “off-target” effects. However, in recent years, advances in the study of the therapeutic effects of inorganic compounds, particularly at the nanoscale level, have opened new and exciting avenues for therapeutic intervention.